Cayuga Biotech

HemostODHealthcare BiotechSwitzerland

69% match

HemostOD is a preclinical-stage biotech company based in Lausanne, Switzerland, pioneering the ex vivo manufacturing of donor-free, off-the-shelf universal human blood platelets to save lives.

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.

Hemoglobin Oxygen Therapeutics LLC develops oxygen-carrying solutions, such as its Hemopure product, for medical applications including organ transplants and preservation. The company serves the healthcare and medical research sectors by providing hemoglobin-based therapeutics used in clinical studies and surgical procedures.

RallybioRLYB · BiotechnologyNew Haven, United States

67% matchPublic

Rallybio is a clinical-stage biotechnology company that develops therapies for patients with severe and rare diseases, focusing on areas such as complement dysregulation and hematology. The company's pipeline includes therapeutic assets like C5 inhibitors designed to address significant unmet medical needs.

Acticor Biotech is a clinical-stage biopharmaceutical company headquartered in Paris, France, that specializes in developing innovative treatments for acute thrombotic diseases.

AptahemBiotechSweden

67% match

Aptahem AB is a clinical-stage biotechnology company that develops RNA-based pharmaceuticals, also known as aptamers, for the treatment of acute conditions such as sepsis.